China now accepting Clinical Trial Data from other Countries

CFDA issued a new guideline announcing that for submissions clinical trial data from other countries will be accepted

A new guideline was issued by the General Office of the Communist Party of China Central Committee and the General Office of the State Council early October. According to a post by the State Council, the guideline aims to promote “the adjustment of industrial structure and technological innovation in the sector of drugs and medical devices, improving industrial competitiveness, and meeting the public’s clinical needs.”